Activation of c-Jun N-terminal kinase and p38 after cerebral ischemia upregulates cerebral sodium-glucose transporter type 1

Journal of Pharmacological Sciences

Volumn 138, Issue 4, 2018, Pages 240-246

  Yamazaki, Yui ^a   Arita, Kyoko ^a   Harada, Shinichi ^a   Tokuyama, Shogo ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

Author keywords

Cerebral ischemia; Hyperglycemia; MAPK; Sodium glucose transporter type 1

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; MITOGEN ACTIVATED PROTEIN KINASE P38; SODIUM GLUCOSE COTRANSPORTER 1; STRESS ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE; SLC5A1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVE CELL LESION; NEUROLOGIC EXAMINATION; NONHUMAN; PROTEIN EXPRESSION; REPERFUSION; UPREGULATION; WESTERN BLOTTING; ANIMAL; CEREBRAL ARTERY DISEASE; METABOLISM; NERVE CELL; PATHOLOGY;

ANIMALS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NEURONS; SODIUM-GLUCOSE TRANSPORTER 1; UP-REGULATION;

EID: 85040686065     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1016/j.jphs.2017.02.016     Document Type: Article

References (47)

1. Choi, K.-H., Park, M.-S., Kim, J.-T., et al. Lipoic acid use and functional outcomes after thrombolysis in patients with acute ischemic stroke and diabetes. PLoS One, 11, 2016, e0163484.
2. Luvizutto, G.J., Bertotti, M.F.Z., Fernandes, T.D., et al. Association between clinical condition and F-waves changes in the acute phase of stroke. Arq Neuropsiquiatr 74 (2016), 708–712.
3. Yao, M., Ni, J., Zhou, L., Peng, B., Zhu, Y., Cui, L., Elevated Fasting Blood Glucose Is Predictive of Poor Outcome in Non-Diabetic Stroke Patients: a Sub-Group Analysis of SMART. PLoS One, 11, 2016, e0160674.
4. Scott, J.F., Robinson, G.M., French, J.M., O'Connell, J.E., Alberti, K.G., Gray, C.S., Prevalence of admission hyperglycaemia across clinical subtypes of acute stroke. Lancet (London, England) 353 (1999), 376–377.
5. Sarwar, N., Gao, P., Seshasai, S.R.K., et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375 (2010), 2215–2222.
6. Harada, S., Fujita, W.H., Shichi, K., Tokuyama, S., The development of glucose intolerance after focal cerebral ischemia participates in subsequent neuronal damage. Brain Res 1279 (2009), 174–181.
7. Harada, S., Fujita-Hamabe, W., Tokuyama, S., The importance of regulation of blood glucose levels through activation of peripheral 5’-AMP-activated protein kinase on ischemic neuronal damage. Brain Res 1351 (2010), 254–263.
8. Harada, S., Fujita-Hamabe, W., Tokuyama, S., Effect of orexin-A on post-ischemic glucose intolerance and neuronal damage. J Pharmacol Sci 115 (2011), 155–163.
9. Harada, S., Fujita-Hamabe, W., Tokuyama, S., Ameliorating effect of hypothalamic brain-derived neurotrophic factor against impaired glucose metabolism after cerebral ischemic stress in mice. J Pharmacol Sci 118 (2012), 109–116.
10. Harada, S., Yamazaki, Y., Tokuyama, S., Orexin-A suppresses postischemic glucose intolerance and neuronal damage through hypothalamic brain-derived neurotrophic factor. J Pharmacol Exp Therapeut 344 (2013), 276–285.
11. Harada, S., Yamazaki, Y., Nishioka, H., Tokuyama, S., Neuroprotective effect through the cerebral sodium-glucose transporter on the development of ischemic damage in global ischemia. Brain Res 1541 (2013), 61–68.
12. Yamazaki, Y., Harada, S., Tokuyama, S., Post-ischemic hyperglycemia exacerbates the development of cerebral ischemic neuronal damage through the cerebral sodium-glucose transporter. Brain Res 1489 (2012), 113–120.
13. Yamazaki, Y., Harada, S., Tokuyama, S., Relationship between cerebral sodium-glucose transporter and hyperglycemia in cerebral ischemia. Neurosci Lett 604 (2015), 134–139.
14. Yamazaki, Y., Ogihara, S., Harada, S., Tokuyama, S., Activation of cerebral sodium-glucose transporter type 1 function mediated by post-ischemic hyperglycemia exacerbates the development of cerebral ischemia. Neuroscience 310 (2015), 674–685.
15. Yamazaki, Y., Harada, S., Wada, T., Yoshida, S., Tokuyama, S., Sodium transport through the cerebral sodium-glucose transporter exacerbates neuron damage during cerebral ischaemia. J Pharm Pharmacol 68 (2016), 922–931.
16. Wright, E.M., Turk, E., The sodium/glucose cotransport family SLC5. Pflügers Archiv 447 (2004), 510–518.
17. Wright, E.M., Loo, D.D.F., Hirayama, B.A., Biology of human sodium glucose transporters. Physiol Rev 91 (2011), 733–794.
18. Wright, E.M., Renal Na+-glucose cotransporters. Am J Physiol Renal Physiol 280 (2001), 10–18.
19. +-dependent and phlorizin-inhibitable transport of glucose and cycasin in brain endothelial cells. J Neurochem 70 (1998), 772–777.
20. Kuhre, R.E., Frost, C.R., Svendsen, B., Holst, J.J., Molecular mechanisms of glucose-stimulated GLP-1 secretion from perfused rat small intestine. Diabetes 64 (2015), 370–382.
21. Scheepers, A., Joost, H.-G., Schürmann, A., The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function. JPEN - J Parenter Enter Nutr 28 (2004), 364–371.
22. +-D-glucose cotransporter SGLT1 in neurons. J Neurochem 69 (1997), 84–94.
23. O'Malley, D., Reimann, F., Simpson, A.K., Gribble, F.M., Sodium-coupled glucose cotransporters contribute to hypothalamic glucose sensing. Diabetes 55 (2006), 3381–3386.
24. Gonzàlez, J.A., Reimann, F., Burdakov, D., Dissociation between sensing and metabolism of glucose in sugar sensing neurones. J Physiol 587 (2009), 41–48.
25. Xie, Y., Chen, S., Wu, Y., Murphy, T.H., Prolonged deficits in parvalbumin neuron stimulation-evoked network activity despite recovery of dendritic structure and excitability in the somatosensory cortex following global ischemia in mice. J Neurosci 34 (2014), 14890–14900.
26. Zheng, L.-S., Ishii, Y., Zhao, Q.-L., Kondo, T., Sasahara, M., PDGF suppresses oxidative stress induced Ca2+ overload and calpain activation in neurons. Oxid Med Cell Longev, 2013, 2013, 367206.
27. Nicolas, G., Bennoun, M., Porteu, A., et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci U S A 99 (2002), 4596–4601.
28. Drenckhahn, C., Koch, S.P., Dümmler, J., Kohl-Bareis, M., Steinbrink, J., Dreier, J.P., A validation study of the use of near-infrared spectroscopy imaging in primary and secondary motor areas of the human brain. Epilepsy Behav 49 (2015), 118–125.
29. Darling, N.J., Cook, S.J., The role of MAPK signalling pathways in the response to endoplasmic reticulum stress. Biochim Biophys Acta 1843 (2014), 2150–2163.
30. Kyosseva, S.V., Targeting MAPK signaling in age-related macular degeneration. Ophthalmol Eye Dis 8 (2016), 23–30.
31. Low, H.B., Zhang, Y., Regulatory roles of MAPK phosphatases in cancer. Immune Netw 16 (2016), 85–98.
32. Javadov, S., Jang, S., Agostini, B., Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectives. Pharmacol Ther 144 (2014), 202–225.
33. Su, L., Du, H., Dong, X., Zhang, X., Lou, Z., Raf kinase inhibitor protein regulates oxygen-glucose deprivation-induced PC12 cells apoptosis through the NF-κB and ERK pathways. J Clin Biochem Nutr 59 (2016), 86–92.
34. Verma, R., Harris, N.M., Friedler, B.D., et al. Reversal of the detrimental effects of post-stroke social isolation by pair-housing is mediated by activation of BDNF-MAPK/ERK in aged mice. Sci Rep, 6, 2016, 25176.
35. Zhen, Y., Ding, C., Sun, J., Wang, Y., Li, S., Dong, L., Activation of the calcium-sensing receptor promotes apoptosis by modulating the JNK/p38 MAPK pathway in focal cerebral ischemia-reperfusion in mice. Am J Transl Res 8 (2016), 911–921.
36. Ruess, D.A., Probst, M., Marjanovic, G., et al. HDACi Valproic Acid (VPA) and Suberoylanilide Hydroxamic Acid (SAHA) delay but fail to protect against warm hepatic ischemia-reperfusion injury. PLoS One, 11, 2016, e0161233.
37. Li, Z., Fang, F., Wang, Y., Wang, L., Resveratrol protects CA1 neurons against focal cerebral ischemic reperfusion-induced damage via the ERK-CREB signaling pathway in rats. Pharmacol Biochem Behav 146–147 (2016), 21–27.
38. Clausen, B.H., Degn, M., Sivasaravanaparan, M., et al. Conditional ablation of myeloid TNF increases lesion volume after experimental stroke in mice, possibly via altered ERK1/2 signaling. Sci Rep, 6, 2016, 29291.
39. Lee, Y.J., Suh, H.N., Han, H.J., Effect of BSA-induced ER stress on SGLT protein expression levels and alpha-MG uptake in renal proximal tubule cells. Am J Physiol Renal Physiol 296 (2009), 1405–1416.
40. Lee, Y.J., Han, H.J., Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells. Am J Physiol Renal Physiol 298 (2010), 1263–1275.
41. Yamazaki, Y., Harada, S., Tokuyama, S., Sodium-glucose transporter type 3-mediated neuroprotective effect of acetylcholine suppresses the development of cerebral ischemic neuronal damage. Neuroscience 269 (2014), 134–142.
42. Haley, T.J., McCormick, W.G., Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol Chemother 12 (1957), 12–15.
43. Zhou J, Du T, Li B, Rong Y, Verkhratsky A, Peng L. Crosstalk between MAPK/ERK and PI3K/AKT signal pathways during brain ischemia/reperfusion. ASN Neuro 7.
44. Wang, Z., Leng, Y., Wang, J., et al. Tubastatin A, an HDAC6 inhibitor, alleviates stroke-induced brain infarction and functional deficits: potential roles of α-tubulin acetylation and FGF-21 up-regulation. Sci Rep, 6, 2016, 19626.
45. Koh, P.-O., Ferulic acid attenuates the down-regulation of MEK/ERK/p90RSK signaling pathway in focal cerebral ischemic injury. Neurosci Lett 588 (2015), 18–23.
46. Takekawa, M., Tatebayashi, K., Saito, H., Conserved docking site is essential for activation of mammalian MAP kinase kinases by specific MAP kinase kinase kinases. Mol Cell 18 (2005), 295–306.
47. Su, C., Sun, F., Cunningham, R.L., Rybalchenko, N., Singh, M., ERK5/KLF4 signaling as a common mediator of the neuroprotective effects of both nerve growth factor and hydrogen peroxide preconditioning. Age (Dordr), 36, 2014, 9685.